☆ 4.5 Letter

Pharmacological management of narcolepsy in children and adolescents

JOURNAL OF SLEEP RESEARCH (2023)

Related references

Note: Only part of the references are listed.

Article Clinical Neurology

Real-world treatment of pediatric narcolepsy with pitolisant: A retrospective, multicenter study

Annika Triller et al.

Summary: This study evaluated the effects and tolerability of pitolisant treatment in children and adolescents with narcolepsy. The results showed that pitolisant treatment effectively improved excessive daytime sleepiness and cataplexy, and it was well tolerated.

SLEEP MEDICINE (2023)

Add to Collection

Article Clinical Neurology

Safety and efficacy of pitolisant in children aged 6 years or older with narcolepsy with or without cataplexy: a double-blind, randomised, placebo-controlled trial

Yves Dauvilliers et al.

LANCET NEUROLOGY (2023)

Add to Collection

Article Clinical Neurology

European guideline and expert statements on the management of narcolepsy in adults and children

Claudio L. A. Bassetti et al.

Summary: This paper provides evidence-based guidelines for the management of narcolepsy in adults and children, with main recommendations focusing on treatment options for excessive daytime sleepiness and cataplexy, tailored to each patient's individual circumstances.

EUROPEAN JOURNAL OF NEUROLOGY (2021)

Add to Collection

Review Clinical Neurology

Clinical Characteristics and Burden of Illness in Pediatric Patients with Narcolepsy

Giuseppe Plazzi et al.

PEDIATRIC NEUROLOGY (2018)

Add to Collection

Review Clinical Neurology

The clinical spectrum of childhood narcolepsy

Emanuela Postiglione et al.

SLEEP MEDICINE REVIEWS (2018)

Add to Collection

Article Clinical Neurology

Clinical experience suggests that modafinil is an effective and safe treatment for paediatric narcolepsy

Michel Lecendreux et al.

JOURNAL OF SLEEP RESEARCH (2012)

Add to Collection

Pharmacological management of narcolepsy in children and adolescents

Related references

Real-world treatment of pediatric narcolepsy with pitolisant: A retrospective, multicenter study

Safety and efficacy of pitolisant in children aged 6 years or older with narcolepsy with or without cataplexy: a double-blind, randomised, placebo-controlled trial

European guideline and expert statements on the management of narcolepsy in adults and children

Clinical Characteristics and Burden of Illness in Pediatric Patients with Narcolepsy

The clinical spectrum of childhood narcolepsy

Clinical experience suggests that modafinil is an effective and safe treatment for paediatric narcolepsy

Export Citation

Share Paper